SAGE

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Sage Therapeutics (SAGE) Earnings Date & Reports

Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on brain health medicines... Show more

Industry: #Pharmaceuticals Other

Get AI intraday signals

A.I. Advisor

published Earnings

SAGE is expected to report earnings to fall 36.23% to -99 cents per share on April 29

Sage Therapeutics SAGE Stock Earnings Reports

Q1'25

Est.

$-0.99

Q4'24

Missed

by $0.06

Q3'24

Beat

by $0.01

Q2'24

Missed

by $0.06

Q1'24

Missed

by $0.15

The last earnings report on February 11 showed earnings per share of -155 cents, missing the estimate of -150 cents. With 285.55K shares outstanding, the current market capitalization sits at 468.48M.

View a ticker or compare two or three

Compare

SAGE

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For SAGE
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for SAGE (Try 14 days for Free)

A.I. Advisor

published General Information

General Information

a developer of therapeutics and medicines for central nervous system disorders

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Pharmaceuticals Other

Address

215 First Street

Phone

+1 617 299-8380

Employees

487

Web

https://www.sagerx.com